The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility
The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator IC...
Saved in:
Published in | The Journal of pharmacology and experimental therapeutics Vol. 354; no. 3; pp. 290 - 301 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.09.2015
The American Society for Pharmacology and Experimental Therapeutics |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K+ (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca2+ concentration in DSM cells, an effect blocked by the L-type Ca2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels. |
---|---|
AbstractList | The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K+ (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca2+ concentration in DSM cells, an effect blocked by the L-type Ca2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels. The physiologic roles of voltage-gated K V 7 channel subtypes (K V 7.1–K V 7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of K V 7.2/K V 7.3 channels in guinea pig DSM excitability and contractility using the novel K V 7.2/K V 7.3 channel activator ICA-069673 [ N -(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca 2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of K V 7.2 and K V 7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for K V 7.2 and K V 7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the K V 7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10 H )-anthracenone dihydrochloride]. Under conditions of elevated extracellular K + (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca 2+ concentration in DSM cells, an effect blocked by the L-type Ca 2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel K V 7.2/K V 7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the K V 7.2- and K V 7.3-containing channels in DSM function at both cellular and tissue levels. The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels. The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels. |
Author | Provence, Aaron Malysz, John Petkov, Georgi V. |
Author_xml | – sequence: 1 givenname: Aaron surname: Provence fullname: Provence, Aaron – sequence: 2 givenname: John surname: Malysz fullname: Malysz, John – sequence: 3 givenname: Georgi V. surname: Petkov fullname: Petkov, Georgi V. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26087697$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UcFu1DAQtVAR3bacuSEfuWTXsWMnuSChpS2I0qJuy9VynHHXVdZO7WTFfgz_iqMtFVSCiz2aee_N6L0jdOC8A4Te5GSe57RY3PcwpIrPKeVUVC_QLOc0z0hO2AGaEUJpxrjgh-goxntC8qIQ7BU6pIJUpajLGfp5swZ86bfQ4S_fyzldTC_Dy7VyLvWuenAQ8Oflh4yIWpQMX8MWVBfxamyGXQ_ZqgdtjdX4bHR6sN6pDl_7DiK2Dp-P1oHC3-wd_ghDGKMPeLXxfljjr2PUHeDTH9oOqrGdHXZYuRYvvRuCSkpT5wS9NGkZvH78j9Ht2enN8lN2cXWebrrINONVlRlWsxo4NIy0pDYNawRRCjjnhWGmMoLWbZqVLDlFNC_a1rQGqE6msbYuGDtG7_e6_dhsoNUw3dDJPtiNCjvplZV_T5xdyzu_lQVnVVVOAu8eBYJ_GCEOcmOjhq5TDvwYZS7qqhZF8jBB3_6562nJ70wSYLEH6OBjDGCeIDmRU-pySj1VXO5TTwz-jDGZOoWRjrXdf3j1ngfJ262FIKO24DS0NoAeZOvtP7m_AKdfxZ8 |
CitedBy_id | crossref_primary_10_1113_JP277021 crossref_primary_10_1124_jpet_117_243162 crossref_primary_10_1016_j_pharmthera_2016_05_002 crossref_primary_10_3389_fphys_2020_01004 crossref_primary_10_1113_JP284744 crossref_primary_10_1080_17460441_2024_2438226 crossref_primary_10_1152_ajpcell_00055_2019 crossref_primary_10_1002_nau_24228 crossref_primary_10_1039_D0MD00328J crossref_primary_10_1038_s41380_023_02218_5 crossref_primary_10_3389_fphar_2023_1138556 crossref_primary_10_14814_phy2_14754 crossref_primary_10_1111_bcpt_13881 crossref_primary_10_1152_ajprenal_00048_2020 |
Cites_doi | 10.1152/physrev.00038.2003 10.1111/bph.12805 10.1111/j.1528-1167.2012.03441.x 10.1016/j.tips.2007.11.010 10.1021/ml200053x 10.1124/mol.114.093799 10.1097/FJC.0b013e3182771708 10.1152/ajpregu.00142.2014 10.1124/pr.56.4.4 10.1152/ajplung.00194.2011 10.1016/j.drudis.2013.12.003 10.1124/mol.107.043216 10.1111/j.1476-5381.2010.01027.x 10.1124/jpet.108.137794 10.1371/journal.pone.0117350 10.1152/ajpgi.00057.2009 10.1161/CIRCULATIONAHA.111.032136 10.1111/j.1476-5381.2009.00131.x 10.1371/journal.pone.0075875 10.3389/fphar.2012.00142 10.1152/ajpcell.00447.2011 10.1097/01.ju.0000138155.33749.f4 10.1016/j.ejphar.2013.05.005 10.1038/nrurol.2011.194 10.1111/bph.12210 10.1073/pnas.0911294107 10.1111/j.1742-7843.2011.00765.x 10.1111/j.1528-1167.2011.03365.x 10.1016/j.ejphar.2010.03.050 10.1016/S0163-7258(01)00116-4 10.1152/ajpregu.00036.2010 10.1152/ajplung.00253.2013 10.1161/ATVBAHA.114.303405 10.1152/ajpcell.00169.2012 10.1152/ajpcell.00303.2010 |
ContentType | Journal Article |
Copyright | 2015 American Society for Pharmacology and Experimental Therapeutics Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics 2015 |
Copyright_xml | – notice: 2015 American Society for Pharmacology and Experimental Therapeutics – notice: Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. – notice: Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1124/jpet.115.225268 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | KV7.2/KV7.3 Channels and Bladder Function |
EISSN | 1521-0103 |
EndPage | 301 |
ExternalDocumentID | PMC4538873 26087697 10_1124_jpet_115_225268 S0022356524191057 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: R01-DK084284 – fundername: NIDDK NIH HHS grantid: R01 DK084284 – fundername: NIDDK NIH HHS grantid: F31-DK104528 – fundername: NIDDK NIH HHS grantid: F31 DK104528 – fundername: NIGMS NIH HHS grantid: P20-GM109091 – fundername: NIGMS NIH HHS grantid: P20 GM109091 |
GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AAJMC AALRI AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AFFNX AFHIN AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM O9- OHT OK1 P2P PKN R.V R0Z RHF RHI ROL RPT TR2 UQL VH1 W2D W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP AAYXX ACVFH ADCNI AETEA AEUPX AFPUW AIGII AKBMS AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c3588-f3939e5eb30d09fb3b60aae5554f3f8f629db30731150c54ddfdfe2c2253d9433 |
ISSN | 0022-3565 1521-0103 |
IngestDate | Thu Aug 21 18:14:07 EDT 2025 Fri Jul 11 07:57:12 EDT 2025 Sat Mar 08 01:25:23 EST 2025 Thu Apr 24 22:50:00 EDT 2025 Tue Jul 01 05:28:18 EDT 2025 Sat Feb 15 15:51:29 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | PBS DMSO L-364,373 KV ICA-27243 ML-213 BSA OAB EFS CaV TTX XE991 ICA-069673 DSM |
Language | English |
License | Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3588-f3939e5eb30d09fb3b60aae5554f3f8f629db30731150c54ddfdfe2c2253d9433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://jpet.aspetjournals.org/content/jpet/354/3/290.full.pdf |
PMID | 26087697 |
PQID | 1698964069 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4538873 proquest_miscellaneous_1698964069 pubmed_primary_26087697 crossref_primary_10_1124_jpet_115_225268 crossref_citationtrail_10_1124_jpet_115_225268 elsevier_sciencedirect_doi_10_1124_jpet_115_225268 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2015 2015-09-00 2015-Sep 20150901 |
PublicationDateYYYYMMDD | 2015-09-01 |
PublicationDate_xml | – month: 09 year: 2015 text: September 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Bethesda, MD |
PublicationTitle | The Journal of pharmacology and experimental therapeutics |
PublicationTitleAlternate | J Pharmacol Exp Ther |
PublicationYear | 2015 |
Publisher | Elsevier Inc The American Society for Pharmacology and Experimental Therapeutics |
Publisher_xml | – name: Elsevier Inc – name: The American Society for Pharmacology and Experimental Therapeutics |
References | Anderson, Carson, Johnston, Joshi, Gurney, McCloskey (bib4) 2013; 169 Svalø, Bille, Parameswaran Theepakaran, Sheykhzade, Nordling, Bouchelouche (bib34) 2013; 715 Andersson, Wein (bib6) 2004; 56 Gunthorpe, Large, Sankar (bib15) 2012; 53 Amato, Roeloffs, Rigdon, Antonio, Mersch, McNaughton-Smith, Wickenden, Fritch, Suto (bib3) 2011; 2 Ng, Davis, Jepps, Harhun, Yeung, Wan, Reddy, Melville, Nardi, Khong (bib22) 2011; 162 Smith, Hristov, Cheng, Xin, Parajuli, Earley, Malysz, Petkov (bib30) 2013; 304 Andersson, Arner (bib5) 2004; 84 Sheldon J, Davis A, Wesley Norton N, Woods M, Carson N, Wang Q, Mitchell R, Littrell J, and Argentieri T (2002) Evidence for KCNQ gene expression and M-current activity in rat and human urinary bladder smooth muscle (Abstract), in ASPET–Ray Fuller Symposium Series: Diseases of Aging-1: Lower Urinary Tract Disorders–Physiology, Pharmacology and Therapeutic Approaches; 2002 Jul 6–7; San Francisco, CA. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD. Svalø, Hansen, Rønn, Sheykhzade, Munro, Rode (bib35) 2012; 110 Svalø, Sheykhzade, Nordling, Matras, Bouchelouche (bib36) 2015; 10 Afeli, Malysz, Petkov (bib2) 2013; 8 Brickel, Gandhi, VanLandingham, Hammond, DeRossett (bib8) 2012; 53 Roeloffs, Wickenden, Crean, Werness, McNaughton-Smith, Stables, McNamara, Ghodadra, Rigdon (bib28) 2008; 326 Soldovieri, Miceli, Taglialatela (bib31) 2011; 26 Xiong, Gao, Wang, Li (bib39) 2008; 29 Brueggemann, Haick, Neuburg, Tate, Randhawa, Cribbs, Byron (bib10) 2014; 306 Mani, O’Dowd, Kumar, Brueggemann, Ross, Byron (bib21) 2013; 61 Chadha, Jepps, Carr, Stott, Zhu, Cole, Greenwood (bib12) 2014; 34 Argentieri T, Sheldon J, and Bowlby M (2002), inventors, American Home Products Corporation, assignee. Methods for modulating bladder function. U.S. patent 6348486. 2002 Feb 19. Hristov, Chen, Soder, Parajuli, Cheng, Kellett, Petkov (bib17) 2012; 302 Jepps, Chadha, Davis, Harhun, Cockerill, Olesen, Hansen, Greenwood (bib19) 2011; 124 Jepps, Bentzen, Stott, Povstyan, Sivaloganathan, Dalby-Brown, Greenwood (bib18) 2014; 171 Brueggemann, Kakad, Love, Solway, Dowell, Cribbs, Byron (bib11) 2012; 302 Chen, Kellett, Petkov (bib13) 2010; 299 Wrobel, Tapken, Seebohm (bib38) 2012; 3 Jepps, Greenwood, Moffatt, Sanders, Ohya (bib20) 2009; 297 Wickenden, Krajewski, London, Wagoner, Wilson, Clark, Roeloffs, McNaughton-Smith, Rigdon (bib37) 2008; 73 Brueggemann, Haick, Cribbs, Byron (bib9) 2014; 86 Abbott, Goldstein (bib1) 2001; 1 Petkov (bib25) 2014; 307 Greenwood, Ohya (bib14) 2009; 156 Robbins (bib26) 2001; 90 Streng, Christoph, Andersson (bib33) 2004; 172 Hristov, Chen, Afeli, Cheng, Rovner, Petkov (bib16) 2012; 302 Peretz, Pell, Gofman, Haitin, Shamgar, Patrich, Kornilov, Gourgy-Hacohen, Ben-Tal, Attali (bib23) 2010; 107 Rode, Svalø, Sheykhzade, Rønn (bib27) 2010; 638 Stott, Jepps, Greenwood (bib32) 2014; 19 Petkov (bib24) 2012; 9 Rode (10.1124/jpet.115.225268_bib27) 2010; 638 Brueggemann (10.1124/jpet.115.225268_bib9) 2014; 86 Roeloffs (10.1124/jpet.115.225268_bib28) 2008; 326 Chen (10.1124/jpet.115.225268_bib13) 2010; 299 Jepps (10.1124/jpet.115.225268_bib19) 2011; 124 Mani (10.1124/jpet.115.225268_bib21) 2013; 61 Peretz (10.1124/jpet.115.225268_bib23) 2010; 107 Svalø (10.1124/jpet.115.225268_bib35) 2012; 110 Hristov (10.1124/jpet.115.225268_bib17) 2012; 302 Jepps (10.1124/jpet.115.225268_bib20) 2009; 297 Soldovieri (10.1124/jpet.115.225268_bib31) 2011; 26 Amato (10.1124/jpet.115.225268_bib3) 2011; 2 Svalø (10.1124/jpet.115.225268_bib36) 2015; 10 Greenwood (10.1124/jpet.115.225268_bib14) 2009; 156 Wrobel (10.1124/jpet.115.225268_bib38) 2012; 3 Afeli (10.1124/jpet.115.225268_bib2) 2013; 8 Abbott (10.1124/jpet.115.225268_bib1) 2001; 1 Anderson (10.1124/jpet.115.225268_bib4) 2013; 169 Chadha (10.1124/jpet.115.225268_bib12) 2014; 34 Hristov (10.1124/jpet.115.225268_bib16) 2012; 302 Robbins (10.1124/jpet.115.225268_bib26) 2001; 90 10.1124/jpet.115.225268_bib29 Brickel (10.1124/jpet.115.225268_bib8) 2012; 53 Xiong (10.1124/jpet.115.225268_bib39) 2008; 29 Brueggemann (10.1124/jpet.115.225268_bib10) 2014; 306 Wickenden (10.1124/jpet.115.225268_bib37) 2008; 73 10.1124/jpet.115.225268_bib7 Petkov (10.1124/jpet.115.225268_bib25) 2014; 307 Stott (10.1124/jpet.115.225268_bib32) 2014; 19 Ng (10.1124/jpet.115.225268_bib22) 2011; 162 Streng (10.1124/jpet.115.225268_bib33) 2004; 172 Andersson (10.1124/jpet.115.225268_bib6) 2004; 56 Smith (10.1124/jpet.115.225268_bib30) 2013; 304 Andersson (10.1124/jpet.115.225268_bib5) 2004; 84 Brueggemann (10.1124/jpet.115.225268_bib11) 2012; 302 Jepps (10.1124/jpet.115.225268_bib18) 2014; 171 Svalø (10.1124/jpet.115.225268_bib34) 2013; 715 Petkov (10.1124/jpet.115.225268_bib24) 2012; 9 Gunthorpe (10.1124/jpet.115.225268_bib15) 2012; 53 |
References_xml | – volume: 169 start-page: 1290 year: 2013 end-page: 1304 ident: bib4 article-title: Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity publication-title: Br J Pharmacol – volume: 306 start-page: L476 year: 2014 end-page: L486 ident: bib10 article-title: KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways publication-title: Am J Physiol Lung Cell Mol Physiol – volume: 307 start-page: R571 year: 2014 end-page: R584 ident: bib25 article-title: Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology publication-title: Am J Physiol Regul Integr Comp Physiol – volume: 638 start-page: 121 year: 2010 end-page: 127 ident: bib27 article-title: Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder publication-title: Eur J Pharmacol – volume: 86 start-page: 330 year: 2014 end-page: 341 ident: bib9 article-title: Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673 publication-title: Mol Pharmacol – volume: 53 start-page: 412 year: 2012 end-page: 424 ident: bib15 article-title: The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy publication-title: Epilepsia – volume: 110 start-page: 145 year: 2012 end-page: 153 ident: bib35 article-title: Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats publication-title: Basic Clin Pharmacol Toxicol – volume: 172 start-page: 2054 year: 2004 end-page: 2058 ident: bib33 article-title: Urodynamic effects of the K publication-title: J Urol – volume: 302 start-page: C360 year: 2012 end-page: C372 ident: bib17 article-title: K publication-title: Am J Physiol Cell Physiol – volume: 2 start-page: 481 year: 2011 end-page: 484 ident: bib3 article-title: N-pyridyl and pyrimidine benzamides as KCNQ2/Q3 potassium channel openers for the treatment of epilepsy publication-title: ACS Med Chem Lett – volume: 304 start-page: C467 year: 2013 end-page: C477 ident: bib30 article-title: Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology publication-title: Am J Physiol Cell Physiol – volume: 61 start-page: 51 year: 2013 end-page: 62 ident: bib21 article-title: Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm publication-title: J Cardiovasc Pharmacol – volume: 1 start-page: 95 year: 2001 end-page: 107 ident: bib1 article-title: Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs) publication-title: Mol Interv – volume: 9 start-page: 30 year: 2012 end-page: 40 ident: bib24 article-title: Role of potassium ion channels in detrusor smooth muscle function and dysfunction publication-title: Nat Rev Urol – volume: 84 start-page: 935 year: 2004 end-page: 986 ident: bib5 article-title: Urinary bladder contraction and relaxation: physiology and pathophysiology publication-title: Physiol Rev – volume: 26 start-page: 365 year: 2011 end-page: 376 ident: bib31 article-title: Driving with no brakes: molecular pathophysiology of Kv7 potassium channels publication-title: Physiology (Bethesda) – volume: 56 start-page: 581 year: 2004 end-page: 631 ident: bib6 article-title: Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence publication-title: Pharmacol Rev – volume: 326 start-page: 818 year: 2008 end-page: 828 ident: bib28 article-title: In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models publication-title: J Pharmacol Exp Ther – volume: 302 start-page: C1599 year: 2012 end-page: C1608 ident: bib16 article-title: Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle publication-title: Am J Physiol Cell Physiol – volume: 162 start-page: 42 year: 2011 end-page: 53 ident: bib22 article-title: Expression and function of the K publication-title: Br J Pharmacol – volume: 29 start-page: 99 year: 2008 end-page: 107 ident: bib39 article-title: Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds publication-title: Trends Pharmacol Sci – reference: Argentieri T, Sheldon J, and Bowlby M (2002), inventors, American Home Products Corporation, assignee. Methods for modulating bladder function. U.S. patent 6348486. 2002 Feb 19. – volume: 156 start-page: 1196 year: 2009 end-page: 1203 ident: bib14 article-title: New tricks for old dogs: KCNQ expression and role in smooth muscle publication-title: Br J Pharmacol – reference: Sheldon J, Davis A, Wesley Norton N, Woods M, Carson N, Wang Q, Mitchell R, Littrell J, and Argentieri T (2002) Evidence for KCNQ gene expression and M-current activity in rat and human urinary bladder smooth muscle (Abstract), in ASPET–Ray Fuller Symposium Series: Diseases of Aging-1: Lower Urinary Tract Disorders–Physiology, Pharmacology and Therapeutic Approaches; 2002 Jul 6–7; San Francisco, CA. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD. – volume: 53 start-page: 606 year: 2012 end-page: 612 ident: bib8 article-title: The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels publication-title: Epilepsia – volume: 10 start-page: e0117350 year: 2015 ident: bib36 article-title: Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction publication-title: PLoS One – volume: 90 start-page: 1 year: 2001 end-page: 19 ident: bib26 article-title: KCNQ potassium channels: physiology, pathophysiology, and pharmacology publication-title: Pharmacol Ther – volume: 171 start-page: 4413 year: 2014 end-page: 4424 ident: bib18 article-title: Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370 publication-title: Br J Pharmacol – volume: 73 start-page: 977 year: 2008 end-page: 986 ident: bib37 article-title: N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator publication-title: Mol Pharmacol – volume: 107 start-page: 15637 year: 2010 end-page: 15642 ident: bib23 article-title: Targeting the voltage sensor of Kv7.2 voltage-gated K publication-title: Proc Natl Acad Sci USA – volume: 302 start-page: L120 year: 2012 end-page: L132 ident: bib11 article-title: Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy publication-title: Am J Physiol Lung Cell Mol Physiol – volume: 8 start-page: e75875 year: 2013 ident: bib2 article-title: Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle publication-title: PLoS One – volume: 297 start-page: G107 year: 2009 end-page: G115 ident: bib20 article-title: Molecular and functional characterization of Kv7 K publication-title: Am J Physiol Gastrointest Liver Physiol – volume: 715 start-page: 312 year: 2013 end-page: 320 ident: bib34 article-title: Bladder contractility is modulated by Kv7 channels in pig detrusor publication-title: Eur J Pharmacol – volume: 19 start-page: 413 year: 2014 end-page: 424 ident: bib32 article-title: K( publication-title: Drug Discov Today – volume: 34 start-page: 887 year: 2014 end-page: 893 ident: bib12 article-title: Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity publication-title: Arterioscler Thromb Vasc Biol – volume: 299 start-page: R177 year: 2010 end-page: R184 ident: bib13 article-title: Voltage-gated K(+) channels sensitive to stromatoxin-1 regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle publication-title: Am J Physiol Regul Integr Comp Physiol – volume: 124 start-page: 602 year: 2011 end-page: 611 ident: bib19 article-title: Downregulation of Kv7.4 channel activity in primary and secondary hypertension publication-title: Circulation – volume: 3 start-page: 142 year: 2012 ident: bib38 article-title: The KCNE tango - how KCNE1 interacts with Kv7.1 publication-title: Front Pharmacol – volume: 84 start-page: 935 year: 2004 ident: 10.1124/jpet.115.225268_bib5 article-title: Urinary bladder contraction and relaxation: physiology and pathophysiology publication-title: Physiol Rev doi: 10.1152/physrev.00038.2003 – volume: 171 start-page: 4413 year: 2014 ident: 10.1124/jpet.115.225268_bib18 article-title: Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370 publication-title: Br J Pharmacol doi: 10.1111/bph.12805 – volume: 53 start-page: 606 year: 2012 ident: 10.1124/jpet.115.225268_bib8 article-title: The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels publication-title: Epilepsia doi: 10.1111/j.1528-1167.2012.03441.x – ident: 10.1124/jpet.115.225268_bib29 – volume: 26 start-page: 365 year: 2011 ident: 10.1124/jpet.115.225268_bib31 article-title: Driving with no brakes: molecular pathophysiology of Kv7 potassium channels publication-title: Physiology (Bethesda) – volume: 29 start-page: 99 year: 2008 ident: 10.1124/jpet.115.225268_bib39 article-title: Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2007.11.010 – volume: 2 start-page: 481 year: 2011 ident: 10.1124/jpet.115.225268_bib3 article-title: N-pyridyl and pyrimidine benzamides as KCNQ2/Q3 potassium channel openers for the treatment of epilepsy publication-title: ACS Med Chem Lett doi: 10.1021/ml200053x – volume: 86 start-page: 330 year: 2014 ident: 10.1124/jpet.115.225268_bib9 article-title: Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673 publication-title: Mol Pharmacol doi: 10.1124/mol.114.093799 – volume: 61 start-page: 51 year: 2013 ident: 10.1124/jpet.115.225268_bib21 article-title: Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm publication-title: J Cardiovasc Pharmacol doi: 10.1097/FJC.0b013e3182771708 – volume: 307 start-page: R571 year: 2014 ident: 10.1124/jpet.115.225268_bib25 article-title: Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00142.2014 – volume: 56 start-page: 581 year: 2004 ident: 10.1124/jpet.115.225268_bib6 article-title: Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence publication-title: Pharmacol Rev doi: 10.1124/pr.56.4.4 – volume: 302 start-page: L120 year: 2012 ident: 10.1124/jpet.115.225268_bib11 article-title: Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00194.2011 – volume: 19 start-page: 413 year: 2014 ident: 10.1124/jpet.115.225268_bib32 article-title: K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders publication-title: Drug Discov Today doi: 10.1016/j.drudis.2013.12.003 – volume: 73 start-page: 977 year: 2008 ident: 10.1124/jpet.115.225268_bib37 article-title: N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator publication-title: Mol Pharmacol doi: 10.1124/mol.107.043216 – volume: 162 start-page: 42 year: 2011 ident: 10.1124/jpet.115.225268_bib22 article-title: Expression and function of the K+ channel KCNQ genes in human arteries publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2010.01027.x – volume: 326 start-page: 818 year: 2008 ident: 10.1124/jpet.115.225268_bib28 article-title: In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.108.137794 – volume: 10 start-page: e0117350 year: 2015 ident: 10.1124/jpet.115.225268_bib36 article-title: Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction publication-title: PLoS One doi: 10.1371/journal.pone.0117350 – volume: 297 start-page: G107 year: 2009 ident: 10.1124/jpet.115.225268_bib20 article-title: Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00057.2009 – ident: 10.1124/jpet.115.225268_bib7 – volume: 124 start-page: 602 year: 2011 ident: 10.1124/jpet.115.225268_bib19 article-title: Downregulation of Kv7.4 channel activity in primary and secondary hypertension publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.111.032136 – volume: 1 start-page: 95 year: 2001 ident: 10.1124/jpet.115.225268_bib1 article-title: Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs) publication-title: Mol Interv – volume: 156 start-page: 1196 year: 2009 ident: 10.1124/jpet.115.225268_bib14 article-title: New tricks for old dogs: KCNQ expression and role in smooth muscle publication-title: Br J Pharmacol doi: 10.1111/j.1476-5381.2009.00131.x – volume: 8 start-page: e75875 year: 2013 ident: 10.1124/jpet.115.225268_bib2 article-title: Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle publication-title: PLoS One doi: 10.1371/journal.pone.0075875 – volume: 3 start-page: 142 year: 2012 ident: 10.1124/jpet.115.225268_bib38 article-title: The KCNE tango - how KCNE1 interacts with Kv7.1 publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00142 – volume: 302 start-page: C1599 year: 2012 ident: 10.1124/jpet.115.225268_bib16 article-title: Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00447.2011 – volume: 172 start-page: 2054 year: 2004 ident: 10.1124/jpet.115.225268_bib33 article-title: Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats publication-title: J Urol doi: 10.1097/01.ju.0000138155.33749.f4 – volume: 715 start-page: 312 year: 2013 ident: 10.1124/jpet.115.225268_bib34 article-title: Bladder contractility is modulated by Kv7 channels in pig detrusor publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2013.05.005 – volume: 9 start-page: 30 year: 2012 ident: 10.1124/jpet.115.225268_bib24 article-title: Role of potassium ion channels in detrusor smooth muscle function and dysfunction publication-title: Nat Rev Urol doi: 10.1038/nrurol.2011.194 – volume: 169 start-page: 1290 year: 2013 ident: 10.1124/jpet.115.225268_bib4 article-title: Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity publication-title: Br J Pharmacol doi: 10.1111/bph.12210 – volume: 107 start-page: 15637 year: 2010 ident: 10.1124/jpet.115.225268_bib23 article-title: Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0911294107 – volume: 110 start-page: 145 year: 2012 ident: 10.1124/jpet.115.225268_bib35 article-title: Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats publication-title: Basic Clin Pharmacol Toxicol doi: 10.1111/j.1742-7843.2011.00765.x – volume: 53 start-page: 412 year: 2012 ident: 10.1124/jpet.115.225268_bib15 article-title: The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy publication-title: Epilepsia doi: 10.1111/j.1528-1167.2011.03365.x – volume: 638 start-page: 121 year: 2010 ident: 10.1124/jpet.115.225268_bib27 article-title: Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2010.03.050 – volume: 90 start-page: 1 year: 2001 ident: 10.1124/jpet.115.225268_bib26 article-title: KCNQ potassium channels: physiology, pathophysiology, and pharmacology publication-title: Pharmacol Ther doi: 10.1016/S0163-7258(01)00116-4 – volume: 299 start-page: R177 year: 2010 ident: 10.1124/jpet.115.225268_bib13 article-title: Voltage-gated K(+) channels sensitive to stromatoxin-1 regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle publication-title: Am J Physiol Regul Integr Comp Physiol doi: 10.1152/ajpregu.00036.2010 – volume: 306 start-page: L476 year: 2014 ident: 10.1124/jpet.115.225268_bib10 article-title: KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00253.2013 – volume: 34 start-page: 887 year: 2014 ident: 10.1124/jpet.115.225268_bib12 article-title: Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.114.303405 – volume: 304 start-page: C467 year: 2013 ident: 10.1124/jpet.115.225268_bib30 article-title: Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00169.2012 – volume: 302 start-page: C360 year: 2012 ident: 10.1124/jpet.115.225268_bib17 article-title: KV2.1 and electrically silent KV channel subunits control excitability and contractility of guinea pig detrusor smooth muscle publication-title: Am J Physiol Cell Physiol doi: 10.1152/ajpcell.00303.2010 |
SSID | ssj0014463 |
Score | 2.250594 |
Snippet | The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate... The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate... The physiologic roles of voltage-gated K V 7 channel subtypes (K V 7.1–K V 7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 290 |
SubjectTerms | Action Potentials - drug effects Action Potentials - physiology Animals Benzamides - pharmacology Calcium - metabolism Calcium Channels, L-Type - metabolism Cell Membrane - drug effects Cell Membrane - metabolism Gastrointestinal, Hepatic, Pulmonary, and Renal Guinea Pigs KCNQ2 Potassium Channel - metabolism KCNQ3 Potassium Channel - metabolism Male Muscle Contraction - drug effects Muscle Contraction - physiology Muscle, Smooth - drug effects Muscle, Smooth - metabolism Myocytes, Smooth Muscle - drug effects Myocytes, Smooth Muscle - metabolism Potassium - metabolism |
Title | The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility |
URI | https://dx.doi.org/10.1124/jpet.115.225268 https://www.ncbi.nlm.nih.gov/pubmed/26087697 https://www.proquest.com/docview/1698964069 https://pubmed.ncbi.nlm.nih.gov/PMC4538873 |
Volume | 354 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swELfa7mUv076XfcmTpmoShQLmIzxGUbpuVapsS6u-ITCmi9aSKE2qrf_L_tfd2Q44dJG2vhBkcDC6-92dje93hLwvXY65PIHtl8y1weDFdlJk3I7AF_KQe6XnYe7w8Dg6PAk-n4VnW9vU2LW0XOQOv_lrXsldpAptIFfMkv0PydZ_Cg1wDvKFI0gYjv8s4-Pptbiwjk5jBzlO8ZfJlIEKWnG3iJhbn_o9242SKGb4KUAgYTLYC1x8tWX5-XLCrQPwb3pZ8CtyPOE6yMclhKCZNZqcg1nC5Izp3Pp2OQXZWsPlFYzFGvzkk4Vi-lY8Tkh2JfOusMUMfJsUNBn8zhrGbNVxrdKAkRRWh_yjObxopZb8e9m82T0wRFaVm_a24pFY_Jhe16v-E-vUMRc4vLDewaVUctxk2FRrW1lH7ZEOzJGO2yM1kxdUeQpHaJvv44qKy0ynwBS1tdZ-Zpp4Vd5URwtMjfS2I_IDdEQw84Hz0AGr6avyQYZazi6lXsKMElyS2qXc4v4eDfsBeKRuzLbJPR8mQmjJj74038lgMs9qPnx4LU1eBU_fbz0bWa_1gzaFYLenWO2dwkboNX5IHmi1oT0FgEdkS1SPya4WzK89agphj-5SU2RPyG-4TCVKqETJvsQI1RihCiO0wQjVGKFtjNAGI1RihE4qqjBCASN0hRGqMEIVRqiJEQoKRNcw8pScHAzG_UNbFyWxOQvB_pQsYYkIRc7cwk3KnOWRm2UihLC8ZGW3jPykyNFx4lSLh0FRlEUpfA5SYEUSMPaM7FTTSrwgVORBxl2vLLLEDzgv8q6sBB5lPPRjPyg6xFnJKeWasR8Lx1ykcubuBynKGM7CVMm4Qz7UHWaKrGbzrf5K8KmOtVUMnYIGb-70bqUiKXgh_LSYVWK6vEo9rEMbYRZ9hzxXKlOPYKV2HRKvKVN9AzLcr1-pJt8l071W_pd37vmK3G9MymuyA3og3sAsYpG_lUD6A_h0Itw |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Novel+KV7.2%2FKV7.3+Channel+Opener+ICA-069673+Reveals+Subtype-Specific+Functional+Roles+in+Guinea+Pig+Detrusor+Smooth+Muscle+Excitability+and+Contractility&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Provence%2C+Aaron&rft.au=Malysz%2C+John&rft.au=Petkov%2C+Georgi+V.&rft.date=2015-09-01&rft.pub=The+American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=354&rft.issue=3&rft.spage=290&rft.epage=301&rft_id=info:doi/10.1124%2Fjpet.115.225268&rft_id=info%3Apmid%2F26087697&rft.externalDocID=PMC4538873 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |